4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-013816
Chief Development Officer sold 367 shares at $2.77 ($1,018)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-05-16 | Sale | −367 | $2.77 | $1,018 | 59,242 | D |
| Open-market sales · 367 sh · avg $2.77 · $1,018 | |||||||
Loading xslF345X05/form4-05202025_050501.xml…